MY JOURNAL FOR WEDNESDAY MORNING – FEBRUARY 21, 2018 NEWS, BREAKOUTS, MOMENTUM PLAYS, & BOTTOMS This Idea is Now Even More Compelling! Here’s the new Capital Ideas Digest! Our cover story this week is a company with three key catalysts that can drive the stock to gains of more than 50% in the next year. They involve inclement weather, U.S. tax rates and valuation. We have research that says this stock is even more compelling today than it was last Friday after it got hit following the company’s mild earnings disappointment due to one-time costs in one of its regions. Do you like pure play companies? We’ve got new coverage of the purest of plays. This stock could gain 55%.  And we’ve got aRead More →

MY JOURNAL FOR TUESDAY MORNING – FEBRUARY 20, 2018 NEWS, BREAKOUTS, MOMENTUM PLAYS, & BOTTOMS Special Episode: CEOs of Organigram, Namaste, Hiku Brands & FinCanna (Clarification: Health Canada’s Office of Medical Cannabis has provided Namaste Technologies with a Confirmation of Readiness for a license under Canada’s Access to Cannabis for Medical Purposes Regulations for the company’s wholly owned subsidiary, Cannmart Inc. A banner in the interview states Namaste has already received approval, which is incorrect.) Capital Ideas Media publisher Mark Bunting talks again with Namaste Technologies (N:CSE) co-founder and CEO Sean Dollinger about the company’s dizzying pace of deal making. Despite a massive move in theRead More →

(Clarification: Health Canada’s Office of Medical Cannabis has provided Namaste Technologies with a Confirmation of Readiness for a license under Canada’s Access to Cannabis for Medical Purposes Regulations for the company’s wholly owned subsidiary, Cannmart Inc. A banner in the interview states Namaste has already received approval, which is incorrect.) Capital Ideas Media publisher Mark Bunting talks again with Namaste Technologies (N:CSE) co-founder and CEO Sean Dollinger about the company’s dizzying pace of deal making. Despite a massive move in the stock, Dollinger still believes the shares are undervalued compared to peers. Mark Bunting interviews Organigram Holdings (OGI:TSXV) CEO Greg Engel about how the companyRead More →

MY JOURNAL FOR THURSDAY MORNING – FEBRUARY 15, 2018 NEWS, BREAKOUTS, MOMENTUM PLAYS, & BOTTOMS When to sell a stock for fundamental reasons When to sell a stock is one of the toughest questions for an investor to answer. It involves emotions, money and oftentimes ego. All of these aspects can be tough to manage so setting up some rules on when selling a stock is appropriate can make sense. So, let us take a view of when to sell for stock-specific reasons to help make the difficult decision a bit easier. It is important to keep in mind that these reasons to sell are notRead More →

MY JOURNAL FOR WEDNESDAY MORNING – FEBRUARY 14, 2018 NEWS, BREAKOUTS, MOMENTUM PLAYS, & BOTTOMS Low Vol Stocks to Sleep at Night! Dear subscriber, Here’s the new Capital Ideas Digest! Volatility is the word of the moment after last week’s explosion in the market. But an investor can only take so much gyration, and Pepto-Bismol. To that end, this week’s issue features analyst research on a couple of buy right and sit tight stocks. They’re steady, pay dividends, have at least 25% upside, and will allow you to sleep comfortably.  We have research on another well-positioned cannabis company. The analyst gives the stock more than 100% upside.  We also look at a base metals player that could gain 40% in the next 12 months. Read More →